Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital
1
x
$
30.00
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
1
x
$
0.00
Zonisamide for Bipolar Depression by Deborah Dauphinais
1
x
$
30.00
The History of Valproate in Clinical Neuroscience
1
x
$
30.00
Great Expectations in Stereochemistry: Focus on Antidepressants
1
x
$
0.00
Betty Jo Salmeron, MD: Pharmacological Applications of Magnetic Resonance Imaging
1
x
$
30.00
Vanderbilt ADHD Diagnostic Teacher Rating Scale
1
x
$
0.00
Gregory J. Moore, PhD: Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders
1
x
$
30.00
Wender Utah Rating Scale (WURS)
1
x
$
0.00
Hypomania Induced by Escitalopram: 2 Case Reports
1
x
$
30.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
Zung Self-Rating Depression Scale
1
x
$
0.00
Single-Isomer Science: The Phenomenon and Its Terminology
1
x
$
0.00
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
1
x
$
30.00
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
1
x
$
30.00
Major (ICD-10) Depression Inventory
1
x
$
0.00
Philip T. Ninan, MD: Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country
1
x
$
30.00
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
1
x
$
30.00
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
1
x
$
30.00
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
1
x
$
30.00
Antipsychotic Induced Symptomatic Hyperprolactinemia
1
x
$
30.00
View Cart
Checkout
Home
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
“Antipsychotic Induced Symptomatic Hyperprolactinemia” has been added to your cart.
View cart
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 3 Articles
Tags:
antidepressant
,
deprenyl
,
depression
,
donald-s-robinson
,
medworks-media
,
monoamine-oxidase-inhibitors
,
phenelzine
,
psychopharmacology-bulletin
,
selegiline
,
transdermal
,
tranylcypromine
,
tyramine-sensitivity
Description
Description
Donald S. Robinson, MD
GENERAL PSYCHOPHARMACOLOGY
Monoamine Oxidase Inhibitors: A New Generation
Donald S. Robinson, MD
Related products
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Page load link
Go to Top
